mouse anti-psd95 Search Results


93
Bio-Techne corporation psd-95 antibody (7e3)
Psd 95 Antibody (7e3), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/PSD-95+Antibody+(7E3)/bio-techne+corporation___nbp2-12872
Average 93 stars, based on 1 article reviews
psd-95 antibody (7e3) - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Becton Dickinson anti postsynaptic density protein 95 (psd95
Expression levels of proteins obtained from a fraction enriched in cytoplasmic proteins/proteins bound to small organelles. (A) Representative Western blots of CB1R, GluA2R, βArr2, <t>PSD95,</t> p-CaMKII and total CaMKII in females and (I) males. (B–H) Quantification of (A) (Females. CB1R: C, n = 5; PTZ, n = 8; WIN, n = 4; WIN + PTZ, n = 6; GluA2: C, n = 5; PTZ, n = 9; WIN, n = 5; WIN + PTZ, n = 6; βArr2: C, n = 5; PTZ, n = 9; WIN, n = 5; WIN + PTZ, n = 6; PSD95: C, n = 5; PTZ, n = 8; WIN, n = 5; WIN + PTZ, n = 6, p -CaMKIIα: C, n = 5; PTZ, n = 8; WIN, n = 4; WIN + PTZ, n = 5; p -CaMKIIβ: C, n = 5; PTZ, n = 7; WIN, n = 5; WIN + PTZ, n = 5; total CaMKII: C, n = 3; PTZ, n = 4; WIN, n = 3; WIN + PTZ, n = 3). (J–P) Quantification of (D) (Males. CB1R: C, n = 4; PTZ, n = 6; WIN, n = 3; WIN + PTZ, n = 5; GluA2: C, n = 4; PTZ, n = 7; WIN, n = 5; WIN + PTZ, n = 5; βArr2: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; PSD95: C, n = 4; PTZ, n = 6; WIN, n = 4; WIN + PTZ, n = 5, p -CaMKIIα: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; p -CaMKIIβ: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; total CaMKII: C, n = 3; PTZ, n = 4; WIN, n = 3; WIN + PTZ, n = 3). Tubulin was used as protein loading control for all gels. * p < 0.05 and ** p < 0.01, one-way ANOVA with Tukey’s multiple comparisons post hoc .
Anti Postsynaptic Density Protein 95 (Psd95, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/mouse+anti+psd95/pmc09488559-55-27-34
Average 90 stars, based on 1 article reviews
anti postsynaptic density protein 95 (psd95 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
QED Bioscience mouse anti-psd95
Expression levels of proteins obtained from a fraction enriched in cytoplasmic proteins/proteins bound to small organelles. (A) Representative Western blots of CB1R, GluA2R, βArr2, <t>PSD95,</t> p-CaMKII and total CaMKII in females and (I) males. (B–H) Quantification of (A) (Females. CB1R: C, n = 5; PTZ, n = 8; WIN, n = 4; WIN + PTZ, n = 6; GluA2: C, n = 5; PTZ, n = 9; WIN, n = 5; WIN + PTZ, n = 6; βArr2: C, n = 5; PTZ, n = 9; WIN, n = 5; WIN + PTZ, n = 6; PSD95: C, n = 5; PTZ, n = 8; WIN, n = 5; WIN + PTZ, n = 6, p -CaMKIIα: C, n = 5; PTZ, n = 8; WIN, n = 4; WIN + PTZ, n = 5; p -CaMKIIβ: C, n = 5; PTZ, n = 7; WIN, n = 5; WIN + PTZ, n = 5; total CaMKII: C, n = 3; PTZ, n = 4; WIN, n = 3; WIN + PTZ, n = 3). (J–P) Quantification of (D) (Males. CB1R: C, n = 4; PTZ, n = 6; WIN, n = 3; WIN + PTZ, n = 5; GluA2: C, n = 4; PTZ, n = 7; WIN, n = 5; WIN + PTZ, n = 5; βArr2: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; PSD95: C, n = 4; PTZ, n = 6; WIN, n = 4; WIN + PTZ, n = 5, p -CaMKIIα: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; p -CaMKIIβ: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; total CaMKII: C, n = 3; PTZ, n = 4; WIN, n = 3; WIN + PTZ, n = 3). Tubulin was used as protein loading control for all gels. * p < 0.05 and ** p < 0.01, one-way ANOVA with Tukey’s multiple comparisons post hoc .
Mouse Anti Psd95, supplied by QED Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/mouse+anti+psd95/pm35283305-143-45-49
Average 90 stars, based on 1 article reviews
mouse anti-psd95 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Enzo Biochem adi-vam-ps002-e

Adi Vam Ps002 E, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/mouse+anti+psd+95++7e3+1b8/pmc10951640-17-6-2
Average 90 stars, based on 1 article reviews
adi-vam-ps002-e - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biozol Diagnostica Vertrieb GmbH mouse monoclonal anti-psd95 antibody

Mouse Monoclonal Anti Psd95 Antibody, supplied by Biozol Diagnostica Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/mouse+anti+psd+95/pmc03595613-656-3-9
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-psd95 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co mouse anti-psd95
a , b Representative western blots and quantitative data of synaptic AMPA receptors subunits GluA1 and GluA2 levels normalized to Homer1b/c and <t>PSD95</t> in mPFC of WT mice 24 h after SR10067 application ( a ), and 6 h and 24 h post SR1078 injection ( b ). ( n = 5, a : two-tailed Student’s t test: * P = 0.0422 for GluA1, ** P = 0.0069 for GluA2, b : one-way ANOVA with Bonferroni post hoc test: * P < 0.05, *** P < 0.001). c Experimental design: WT mice were subjected to the CDM protocol before undergoing implantation of ECoG, LFP and EMG recording electrodes. After recovery, mice were recorded in their home cage over 32 h from ZT0, with treatment (vehicle/ketamine/SR1078) administered at ZT06. d , e Delta power (0.5–4 Hz) of LFP signal recorded from the mPFC ( d ) and ECoG signal ( e ) recorded during slow wave sleep (SWS) across 12 h:12 h LD conditions ( n = 14 mice CDM/vehicle; n = 6 SR1078; n = 4 KET; repeated measures mixed-effects model two-way ANOVA with Bonferroni post hoc test * P < 0.05, ** P < 0.01 vs CDM/vehicle). Black arrow indicates time of treatment administration. f Schema summarizing the effects of RORα/γ activation on BMAL1, Homer1a and synaptic AMPAR expression in the mPFC and the relation to depression-like behavior. Data are presented as mean ± SEM and the individual data points are depicted. See also Supplementary Fig. and Supplementary Data . Source data are provided as a Source Data file.
Mouse Anti Psd95, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/psd95/pmc11344080-312-43-45
Average 90 stars, based on 1 article reviews
mouse anti-psd95 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
US Biological Life Sciences mouse anti-psd-95 family antibody
a , b Representative western blots and quantitative data of synaptic AMPA receptors subunits GluA1 and GluA2 levels normalized to Homer1b/c and <t>PSD95</t> in mPFC of WT mice 24 h after SR10067 application ( a ), and 6 h and 24 h post SR1078 injection ( b ). ( n = 5, a : two-tailed Student’s t test: * P = 0.0422 for GluA1, ** P = 0.0069 for GluA2, b : one-way ANOVA with Bonferroni post hoc test: * P < 0.05, *** P < 0.001). c Experimental design: WT mice were subjected to the CDM protocol before undergoing implantation of ECoG, LFP and EMG recording electrodes. After recovery, mice were recorded in their home cage over 32 h from ZT0, with treatment (vehicle/ketamine/SR1078) administered at ZT06. d , e Delta power (0.5–4 Hz) of LFP signal recorded from the mPFC ( d ) and ECoG signal ( e ) recorded during slow wave sleep (SWS) across 12 h:12 h LD conditions ( n = 14 mice CDM/vehicle; n = 6 SR1078; n = 4 KET; repeated measures mixed-effects model two-way ANOVA with Bonferroni post hoc test * P < 0.05, ** P < 0.01 vs CDM/vehicle). Black arrow indicates time of treatment administration. f Schema summarizing the effects of RORα/γ activation on BMAL1, Homer1a and synaptic AMPAR expression in the mPFC and the relation to depression-like behavior. Data are presented as mean ± SEM and the individual data points are depicted. See also Supplementary Fig. and Supplementary Data . Source data are provided as a Source Data file.
Mouse Anti Psd 95 Family Antibody, supplied by US Biological Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/mouse+anti+psd+95+family+antibody/10__1161_slash_circresaha__108__191007-396-16-20
Average 90 stars, based on 1 article reviews
mouse anti-psd-95 family antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Fisher Scientific monoclonal mouse anti-psd95
a , b Representative western blots and quantitative data of synaptic AMPA receptors subunits GluA1 and GluA2 levels normalized to Homer1b/c and <t>PSD95</t> in mPFC of WT mice 24 h after SR10067 application ( a ), and 6 h and 24 h post SR1078 injection ( b ). ( n = 5, a : two-tailed Student’s t test: * P = 0.0422 for GluA1, ** P = 0.0069 for GluA2, b : one-way ANOVA with Bonferroni post hoc test: * P < 0.05, *** P < 0.001). c Experimental design: WT mice were subjected to the CDM protocol before undergoing implantation of ECoG, LFP and EMG recording electrodes. After recovery, mice were recorded in their home cage over 32 h from ZT0, with treatment (vehicle/ketamine/SR1078) administered at ZT06. d , e Delta power (0.5–4 Hz) of LFP signal recorded from the mPFC ( d ) and ECoG signal ( e ) recorded during slow wave sleep (SWS) across 12 h:12 h LD conditions ( n = 14 mice CDM/vehicle; n = 6 SR1078; n = 4 KET; repeated measures mixed-effects model two-way ANOVA with Bonferroni post hoc test * P < 0.05, ** P < 0.01 vs CDM/vehicle). Black arrow indicates time of treatment administration. f Schema summarizing the effects of RORα/γ activation on BMAL1, Homer1a and synaptic AMPAR expression in the mPFC and the relation to depression-like behavior. Data are presented as mean ± SEM and the individual data points are depicted. See also Supplementary Fig. and Supplementary Data . Source data are provided as a Source Data file.
Monoclonal Mouse Anti Psd95, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/monoclonal+mouse+anti+psd95/pmc04375531-85-15-21
Average 90 stars, based on 1 article reviews
monoclonal mouse anti-psd95 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sternberger Monoclonals mouse anti-psd-95
a , b Representative western blots and quantitative data of synaptic AMPA receptors subunits GluA1 and GluA2 levels normalized to Homer1b/c and <t>PSD95</t> in mPFC of WT mice 24 h after SR10067 application ( a ), and 6 h and 24 h post SR1078 injection ( b ). ( n = 5, a : two-tailed Student’s t test: * P = 0.0422 for GluA1, ** P = 0.0069 for GluA2, b : one-way ANOVA with Bonferroni post hoc test: * P < 0.05, *** P < 0.001). c Experimental design: WT mice were subjected to the CDM protocol before undergoing implantation of ECoG, LFP and EMG recording electrodes. After recovery, mice were recorded in their home cage over 32 h from ZT0, with treatment (vehicle/ketamine/SR1078) administered at ZT06. d , e Delta power (0.5–4 Hz) of LFP signal recorded from the mPFC ( d ) and ECoG signal ( e ) recorded during slow wave sleep (SWS) across 12 h:12 h LD conditions ( n = 14 mice CDM/vehicle; n = 6 SR1078; n = 4 KET; repeated measures mixed-effects model two-way ANOVA with Bonferroni post hoc test * P < 0.05, ** P < 0.01 vs CDM/vehicle). Black arrow indicates time of treatment administration. f Schema summarizing the effects of RORα/γ activation on BMAL1, Homer1a and synaptic AMPAR expression in the mPFC and the relation to depression-like behavior. Data are presented as mean ± SEM and the individual data points are depicted. See also Supplementary Fig. and Supplementary Data . Source data are provided as a Source Data file.
Mouse Anti Psd 95, supplied by Sternberger Monoclonals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/mouse+anti+psd+95/pmc03526747-48-7-10
Average 90 stars, based on 1 article reviews
mouse anti-psd-95 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biomol GmbH mouse monoclonal anti-psd95
a , b Representative western blots and quantitative data of synaptic AMPA receptors subunits GluA1 and GluA2 levels normalized to Homer1b/c and <t>PSD95</t> in mPFC of WT mice 24 h after SR10067 application ( a ), and 6 h and 24 h post SR1078 injection ( b ). ( n = 5, a : two-tailed Student’s t test: * P = 0.0422 for GluA1, ** P = 0.0069 for GluA2, b : one-way ANOVA with Bonferroni post hoc test: * P < 0.05, *** P < 0.001). c Experimental design: WT mice were subjected to the CDM protocol before undergoing implantation of ECoG, LFP and EMG recording electrodes. After recovery, mice were recorded in their home cage over 32 h from ZT0, with treatment (vehicle/ketamine/SR1078) administered at ZT06. d , e Delta power (0.5–4 Hz) of LFP signal recorded from the mPFC ( d ) and ECoG signal ( e ) recorded during slow wave sleep (SWS) across 12 h:12 h LD conditions ( n = 14 mice CDM/vehicle; n = 6 SR1078; n = 4 KET; repeated measures mixed-effects model two-way ANOVA with Bonferroni post hoc test * P < 0.05, ** P < 0.01 vs CDM/vehicle). Black arrow indicates time of treatment administration. f Schema summarizing the effects of RORα/γ activation on BMAL1, Homer1a and synaptic AMPAR expression in the mPFC and the relation to depression-like behavior. Data are presented as mean ± SEM and the individual data points are depicted. See also Supplementary Fig. and Supplementary Data . Source data are provided as a Source Data file.
Mouse Monoclonal Anti Psd95, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/mouse+monoclonal+anti+psd95/pm15307155-64-2-5
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-psd95 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Bio-Techne corporation psd-95 antibody (6g6-1c9) - bsa free
a , b Representative western blots and quantitative data of synaptic AMPA receptors subunits GluA1 and GluA2 levels normalized to Homer1b/c and <t>PSD95</t> in mPFC of WT mice 24 h after SR10067 application ( a ), and 6 h and 24 h post SR1078 injection ( b ). ( n = 5, a : two-tailed Student’s t test: * P = 0.0422 for GluA1, ** P = 0.0069 for GluA2, b : one-way ANOVA with Bonferroni post hoc test: * P < 0.05, *** P < 0.001). c Experimental design: WT mice were subjected to the CDM protocol before undergoing implantation of ECoG, LFP and EMG recording electrodes. After recovery, mice were recorded in their home cage over 32 h from ZT0, with treatment (vehicle/ketamine/SR1078) administered at ZT06. d , e Delta power (0.5–4 Hz) of LFP signal recorded from the mPFC ( d ) and ECoG signal ( e ) recorded during slow wave sleep (SWS) across 12 h:12 h LD conditions ( n = 14 mice CDM/vehicle; n = 6 SR1078; n = 4 KET; repeated measures mixed-effects model two-way ANOVA with Bonferroni post hoc test * P < 0.05, ** P < 0.01 vs CDM/vehicle). Black arrow indicates time of treatment administration. f Schema summarizing the effects of RORα/γ activation on BMAL1, Homer1a and synaptic AMPAR expression in the mPFC and the relation to depression-like behavior. Data are presented as mean ± SEM and the individual data points are depicted. See also Supplementary Fig. and Supplementary Data . Source data are provided as a Source Data file.
Psd 95 Antibody (6g6 1c9) Bsa Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-psd95/PSD-95+Antibody+(6G6-1C9)+-+BSA+Free/bio-techne+corporation___nb300-556
Average 94 stars, based on 1 article reviews
psd-95 antibody (6g6-1c9) - bsa free - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier


Image Search Results


Expression levels of proteins obtained from a fraction enriched in cytoplasmic proteins/proteins bound to small organelles. (A) Representative Western blots of CB1R, GluA2R, βArr2, PSD95, p-CaMKII and total CaMKII in females and (I) males. (B–H) Quantification of (A) (Females. CB1R: C, n = 5; PTZ, n = 8; WIN, n = 4; WIN + PTZ, n = 6; GluA2: C, n = 5; PTZ, n = 9; WIN, n = 5; WIN + PTZ, n = 6; βArr2: C, n = 5; PTZ, n = 9; WIN, n = 5; WIN + PTZ, n = 6; PSD95: C, n = 5; PTZ, n = 8; WIN, n = 5; WIN + PTZ, n = 6, p -CaMKIIα: C, n = 5; PTZ, n = 8; WIN, n = 4; WIN + PTZ, n = 5; p -CaMKIIβ: C, n = 5; PTZ, n = 7; WIN, n = 5; WIN + PTZ, n = 5; total CaMKII: C, n = 3; PTZ, n = 4; WIN, n = 3; WIN + PTZ, n = 3). (J–P) Quantification of (D) (Males. CB1R: C, n = 4; PTZ, n = 6; WIN, n = 3; WIN + PTZ, n = 5; GluA2: C, n = 4; PTZ, n = 7; WIN, n = 5; WIN + PTZ, n = 5; βArr2: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; PSD95: C, n = 4; PTZ, n = 6; WIN, n = 4; WIN + PTZ, n = 5, p -CaMKIIα: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; p -CaMKIIβ: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; total CaMKII: C, n = 3; PTZ, n = 4; WIN, n = 3; WIN + PTZ, n = 3). Tubulin was used as protein loading control for all gels. * p < 0.05 and ** p < 0.01, one-way ANOVA with Tukey’s multiple comparisons post hoc .

Journal: Frontiers in Molecular Neuroscience

Article Title: Behavioral and Molecular Responses to Exogenous Cannabinoids During Pentylenetetrazol-Induced Convulsions in Male and Female Rats

doi: 10.3389/fnmol.2022.868583

Figure Lengend Snippet: Expression levels of proteins obtained from a fraction enriched in cytoplasmic proteins/proteins bound to small organelles. (A) Representative Western blots of CB1R, GluA2R, βArr2, PSD95, p-CaMKII and total CaMKII in females and (I) males. (B–H) Quantification of (A) (Females. CB1R: C, n = 5; PTZ, n = 8; WIN, n = 4; WIN + PTZ, n = 6; GluA2: C, n = 5; PTZ, n = 9; WIN, n = 5; WIN + PTZ, n = 6; βArr2: C, n = 5; PTZ, n = 9; WIN, n = 5; WIN + PTZ, n = 6; PSD95: C, n = 5; PTZ, n = 8; WIN, n = 5; WIN + PTZ, n = 6, p -CaMKIIα: C, n = 5; PTZ, n = 8; WIN, n = 4; WIN + PTZ, n = 5; p -CaMKIIβ: C, n = 5; PTZ, n = 7; WIN, n = 5; WIN + PTZ, n = 5; total CaMKII: C, n = 3; PTZ, n = 4; WIN, n = 3; WIN + PTZ, n = 3). (J–P) Quantification of (D) (Males. CB1R: C, n = 4; PTZ, n = 6; WIN, n = 3; WIN + PTZ, n = 5; GluA2: C, n = 4; PTZ, n = 7; WIN, n = 5; WIN + PTZ, n = 5; βArr2: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; PSD95: C, n = 4; PTZ, n = 6; WIN, n = 4; WIN + PTZ, n = 5, p -CaMKIIα: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; p -CaMKIIβ: C, n = 4; PTZ, n = 5; WIN, n = 4; WIN + PTZ, n = 5; total CaMKII: C, n = 3; PTZ, n = 4; WIN, n = 3; WIN + PTZ, n = 3). Tubulin was used as protein loading control for all gels. * p < 0.05 and ** p < 0.01, one-way ANOVA with Tukey’s multiple comparisons post hoc .

Article Snippet: Primary antibodies used were anti CB1, 1:1,000 (Ab23703, Abcam, UK), anti βArr2, 1:500 (Ab31294, Abcam), anti phospho T286phosphorylated calcium/calmodulin-dependent protein kinase II (p-CaMKII), 1:2,000 (Ab32678, Abcam), anti postsynaptic density protein 95 (PSD95) 1:1,000 (#610496, BD Biosciences, USA), anti α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, AMPA, subunit GluA2 (GluA2), 1:1,000 (Sc-517265, Santa Cruz Biotechnology, USA), anti calcium/calmodulin-dependent protein kinase II (total CaMKII) (Sc-5306, Santa Cruz Biotechnology), antiGolgi matrix protein 130 (GM130), 1:1,000 (#610823, BD Biosciences, USA), anti βIII-Tubulin, 1:2,500 (G7121, Promega, USA), anti N-cadherin, 1:1,000 (#33-3900, Invitrogen).

Techniques: Expressing, Western Blot, Control

Journal: iScience

Article Title: Local mitochondrial replication in the periphery of neurons requires the eEF1A1 protein and thetranslation of nuclear-encoded proteins

doi: 10.1016/j.isci.2024.109136

Figure Lengend Snippet:

Article Snippet: Anti-PSD95 , Enzo Life Sciences , ADI-VAM-PS002-E; RRID: AB_11180787.

Techniques: Recombinant, Electron Microscopy, Modification, Plasmid Preparation, Protease Inhibitor, Western Blot, Bicinchoninic Acid Protein Assay, shRNA, Sequencing, Software, Microscopy

a , b Representative western blots and quantitative data of synaptic AMPA receptors subunits GluA1 and GluA2 levels normalized to Homer1b/c and PSD95 in mPFC of WT mice 24 h after SR10067 application ( a ), and 6 h and 24 h post SR1078 injection ( b ). ( n = 5, a : two-tailed Student’s t test: * P = 0.0422 for GluA1, ** P = 0.0069 for GluA2, b : one-way ANOVA with Bonferroni post hoc test: * P < 0.05, *** P < 0.001). c Experimental design: WT mice were subjected to the CDM protocol before undergoing implantation of ECoG, LFP and EMG recording electrodes. After recovery, mice were recorded in their home cage over 32 h from ZT0, with treatment (vehicle/ketamine/SR1078) administered at ZT06. d , e Delta power (0.5–4 Hz) of LFP signal recorded from the mPFC ( d ) and ECoG signal ( e ) recorded during slow wave sleep (SWS) across 12 h:12 h LD conditions ( n = 14 mice CDM/vehicle; n = 6 SR1078; n = 4 KET; repeated measures mixed-effects model two-way ANOVA with Bonferroni post hoc test * P < 0.05, ** P < 0.01 vs CDM/vehicle). Black arrow indicates time of treatment administration. f Schema summarizing the effects of RORα/γ activation on BMAL1, Homer1a and synaptic AMPAR expression in the mPFC and the relation to depression-like behavior. Data are presented as mean ± SEM and the individual data points are depicted. See also Supplementary Fig. and Supplementary Data . Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Prefrontal cortex molecular clock modulates development of depression-like phenotype and rapid antidepressant response in mice

doi: 10.1038/s41467-024-51716-9

Figure Lengend Snippet: a , b Representative western blots and quantitative data of synaptic AMPA receptors subunits GluA1 and GluA2 levels normalized to Homer1b/c and PSD95 in mPFC of WT mice 24 h after SR10067 application ( a ), and 6 h and 24 h post SR1078 injection ( b ). ( n = 5, a : two-tailed Student’s t test: * P = 0.0422 for GluA1, ** P = 0.0069 for GluA2, b : one-way ANOVA with Bonferroni post hoc test: * P < 0.05, *** P < 0.001). c Experimental design: WT mice were subjected to the CDM protocol before undergoing implantation of ECoG, LFP and EMG recording electrodes. After recovery, mice were recorded in their home cage over 32 h from ZT0, with treatment (vehicle/ketamine/SR1078) administered at ZT06. d , e Delta power (0.5–4 Hz) of LFP signal recorded from the mPFC ( d ) and ECoG signal ( e ) recorded during slow wave sleep (SWS) across 12 h:12 h LD conditions ( n = 14 mice CDM/vehicle; n = 6 SR1078; n = 4 KET; repeated measures mixed-effects model two-way ANOVA with Bonferroni post hoc test * P < 0.05, ** P < 0.01 vs CDM/vehicle). Black arrow indicates time of treatment administration. f Schema summarizing the effects of RORα/γ activation on BMAL1, Homer1a and synaptic AMPAR expression in the mPFC and the relation to depression-like behavior. Data are presented as mean ± SEM and the individual data points are depicted. See also Supplementary Fig. and Supplementary Data . Source data are provided as a Source Data file.

Article Snippet: The membranes were blocked with 5% non-fat dry milk in TBS-T (1% Tween20 in Tris-buffered saline (TBS)) and afterward incubated with the respective primary antibodies diluted in TBS (mouse anti-GluR1-NT, Merck (MAB2263), 1:1000; rabbit anti-GluR2, Merck (AB1768-I), 1:1000; rabbit anti-Homer1, Merck (ABN37), 1:1000; mouse anti-PSD95, Merck (MABN68), 1:1000; rabbit anti-mouse Per2, Alpha Diagnostics (PER21-A), 1:1000; rabbit anti-BMAL1, Thermo Fisher Scientific PA1-523, 1:1000; mouse anti-Histone H2b, Euromedex (IG-H2-2A8), 1:500 overnight at 4 °C.

Techniques: Western Blot, Injection, Two Tailed Test, Activation Assay, Expressing